Back to User profile » Mr Ye Mao
Papers published by Mr Ye Mao:
Original Research
Low-Dose Versus Standard-Dose Bevacizumab Plus Sintilimab for Unresectable Hepatocellular Carcinoma: A Real-World Comparative Study of Efficacy and Safety
Xu L, Wang X, Lai X, Li A, Mao Y, Wang X, Wu J
Journal of Hepatocellular Carcinoma 2026, 13:582999
Published Date: 12 April 2026
Original Research
Establishment and Validation of a Novel Nutritional-Immune-Inflammatory Score Model for Predicting Survival Prognosis in Hepatocellular Carcinoma Patients Treated with PD-1 Inhibitors
Liu K, Lv Y, Fu S, Mao Y, Xu Y, Huang S, Wu J
Journal of Inflammation Research 2025, 18:13397-13412
Published Date: 27 September 2025
Original Research
Lenvatinib Plus PD-1 Inhibitors versus Regorafenib in Patients with Advanced Hepatocellular Carcinoma After the Failure of Sorafenib: A Retrospective Study
Xu Y, Fu S, Liu K, Mao Y, Wu J
Therapeutics and Clinical Risk Management 2023, 19:853-863
Published Date: 24 October 2023
Original Research
Efficacy and Safety of Regorafenib with or without PD-1 Inhibitors as Second-Line Therapy for Advanced Hepatocellular Carcinoma in Real-World Clinical Practice
Liu K, Wu J, Xu Y, Li D, Huang S, Mao Y
OncoTargets and Therapy 2022, 15:1079-1094
Published Date: 1 October 2022